Cancer Therapy
Ginsenoside Rh-2 enhanced antitumor activity and decreased genotoxicity of cyclophosphamide
Published in Cancer Weekly, June 5th, 2006
"Ginsenoside Rh-2, a panoxadiol saponins, possesses various antitumour properties. Cyclophosphamide, an alkylating agent, has been shown to possess various genotoxic and carcinogenic effects, however, it is still used extensively as an antitumour agent and immunosuppressant in the clinic," researchers in the People's Republic of China reported.
"Previous reports reveal that cyclophosphamide is involved in some secondary neoplasmas," explained Z.H. Wang and colleagues, Lanzhou University. "In this study, the antitumour activity and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-06-05)
More Articles from Cancer Weekly
- Complementary & Alternative Medicine
Cancer therapy efficacy increased by controlling meal timing - Leukemia
Leukemia may be treated by novel polycyclic aromatic hydrocarbons - Skin Cancer
Public health skin cancer prevention policies should prohibit UV tanning advertising to minors - Uveal Melanoma
Uveal melanoma imaging improved with a 3.0-T MRI using a surface coil - Allergy & Immunology
Rheumatoid arthritis drug linked to serious infections and cancers - Anal Cancer
Elevated anal squamous cell carcinoma risk linked to benign inflammatory anal lesions - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
